Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Neural Stem Cell Oncolytic Adenoviral Virotherapy of Newly Diagnosed Malignant Glioma

NCT03072134 is registered in ClinicalTrials.gov with Northwestern University as lead sponsor.

NCT NCT03072134
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03072134 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Neural Stem Cell Oncolytic Adenoviral Virotherapy of Newly Diagnosed Malignant Glioma
Lead sponsor
Northwestern University
Phase
Phase 1
Overall status
Completed
Start date
April 24, 2017
Completion date
July 1, 2021
Enrollment
12 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

anaplastic astrocytoma, anaplastic oligoastrocytoma, anaplastic oligodendroglioma, astrocytoma, grade iii, astrocytoma, grade iv, brain cancer, glioblastoma multiforme, glioma